MAPT and Alzheimer disease: A growing body of research emphasizes the pivotal role of chronic neuroinflammation in AD, particularly the maladaptive activation of microglia in response to extracellular protein aggregates such as amyloid-β and tau (de Oliveira et al., 2021; Bowirrat, 2022; Heneka et al., 2025).